Showing results (571-580 of 857) with videos related to
Sort By:
Pageof 86
Molecular Immunology|August 3, 2006
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndromeAnna Richards, M Kathryn Liszewski, David Kavanagh, et al.Circulation|August 11, 2004
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.Kidney International|May 20, 2004
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.Plos One|April 17, 2018
Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysisUdeme E Ekrikpo, Andre P Kengne, Aminu K Bello, et al.Stem Cell Research & Therapy|February 12, 2026
NAMPT overexpression enhances the regenerative potential of mesenchymal stromal cell-derived extracellular vesicles in experimental AKISimona Buelli, Michelle Prioli Miranda Soares, Anna Pezzotta, et al.Frontiers in Medicine|November 23, 2020
Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 VariantRossella Piras, Paraskevas Iatropoulos, Elena Bresin, et al.Transplantation|February 26, 2019
Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney TransplantationFederica Casiraghi, Marta Todeschini, Nadia Azzollini, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2022
Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 GlomerulopathyCristina Zanchi, Monica Locatelli, Domenico Cerullo, et al.Frontiers in Immunology|February 27, 2023
An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndromeSara Gastoldi, Sistiana Aiello, Miriam Galbusera, et al.Kidney International Reports|January 15, 2025
Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative GlomerulonephritisAndrew S Bomback, Erica Daina, Giuseppe Remuzzi, et al.Pageof 86